REVIEW ARTICLE |
|
Year : 2020 | Volume
: 6
| Issue : 2 | Page : 59-69 |
|
Isotretinoin: In acne and beyond – An overview
Aditya Kumar Bubna
Department of Dermatology, IQ City Medical College, Durgapur, West Bengal, India
Correspondence Address:
Aditya Kumar Bubna Department of Dermatology, IQ City Medical College, Sovapur, Bijra Road, Jemua, Durgapur - 713 206, West Bengal India
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/ijdd.ijdd_11_19
|
|
Isotretinoin (ISO) has proven to be an extremely valuable drug for all dermatologists. Since its approval in 1982 by the US Food and Drug Administration for nodulocystic acne, it still remains the gold standard drug for the above indication till date, facing no competition from its contemporaries. Along with the treatment of nodulocystic acne, ISO has proved valuable in several other dermatoses as well. Further, even for treating acne, there have been a number of modifications as far as the prescription of ISO is concerned. This review will briefly highlight the various aspects of isotretinoin for acne and other cutaneous disorders.
|
|
|
|
[FULL TEXT] [PDF]* |
|
|
|